Tenax Therapeutics (TENX) EPS (Basic) (2016)
Historic EPS (Basic) for Tenax Therapeutics (TENX) over the last 6 years, with Q4 2016 value amounting to $24.08.
- Tenax Therapeutics' EPS (Basic) rose 569439.49% to $24.08 in Q4 2016 from the same period last year, while for Sep 2017 it was $23.98, marking a year-over-year increase of 326950.93%. This contributed to the annual value of -$1.15 for FY2024, which is 9629.51% up from last year.
- According to the latest figures from Q4 2016, Tenax Therapeutics' EPS (Basic) is $24.08, which was up 569439.49% from -$0.16 recorded in Q3 2016.
- In the past 5 years, Tenax Therapeutics' EPS (Basic) ranged from a high of $71.5 in Q2 2013 and a low of -$11.59 during Q2 2012
- Its 4-year average for EPS (Basic) is $7.09, with a median of -$0.26 in 2012.
- As far as peak fluctuations go, Tenax Therapeutics' EPS (Basic) crashed by 959469.15% in 2012, and later soared by 569439.49% in 2016.
- Tenax Therapeutics' EPS (Basic) (Quarter) stood at -$0.97 in 2012, then skyrocketed by 7496.46% to $71.5 in 2013, then plummeted by 100.6% to -$0.43 in 2015, then skyrocketed by 5694.39% to $24.08 in 2016.
- Its EPS (Basic) was $24.08 in Q4 2016, compared to -$0.16 in Q3 2016 and -$0.17 in Q2 2016.